Encoded Therapeutics Inc. . undefined Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

Encoded Therapeutics Inc. is a biotechnology research company based in South San Francisco, California, at 341 Oyster Point Boulevard, with 51 to 200 employees and a website at encoded.com. The company develops one-time, disease-modifying gene therapies for pediatric central nervous system disorders, using a cell-selective targeting and regulation platform. Its platform aims to provide high gene specificity and cell selectivity and can be compatible with various delivery systems to control where and when therapeutic transgenes are expressed, potentially expanding beyond CNS indications. In 2026, Encoded Therapeutics presented clinical data from its POLARIS Phase 1/2 program evaluating ETX101 for Dravet Syndrome at the ASGCT Presidential Symposium. Earlier, in 2021, the company announced initial findings from the ENVISION natural history study of SCN1A+ Dravet syndrome.

Sign up for free to view info

Company overview Employee directory